235 related articles for article (PubMed ID: 3931904)
1. Effects of BMY 25282, a mitomycin C analogue, in mitomycin C-resistant human colon cancer cells.
Willson JK; Long BH; Chakrabarty S; Brattain DE; Brattain MG
Cancer Res; 1985 Nov; 45(11 Pt 1):5281-6. PubMed ID: 3931904
[TBL] [Abstract][Full Text] [Related]
2. Circumvention of deficient activation in mitomycin C-resistant human colonic carcinoma cells by the mitomycin C analogue BMY25282.
Chakrabarty S; Danels YJ; Long BH; Willson JK; Brattain MG
Cancer Res; 1986 Jul; 46(7):3456-8. PubMed ID: 3754788
[TBL] [Abstract][Full Text] [Related]
3. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
Xu BH; Singh SV
Cancer Res; 1992 Dec; 52(23):6666-70. PubMed ID: 1423311
[TBL] [Abstract][Full Text] [Related]
4. Mitomycin C resistance in a human colon carcinoma cell line associated with cell surface protein alterations.
Willson JK; Long BH; Marks ME; Brattain DE; Wiley JE; Brattain MG
Cancer Res; 1984 Dec; 44(12 Pt 1):5880-5. PubMed ID: 6437674
[TBL] [Abstract][Full Text] [Related]
5. Experimental tumor inhibitory and toxic properties of the mitomycin A analogue 7-(2-hydroxyethoxy) mitosane (BMY-25551).
Bradner WT; Catino JJ; Long BH; Rose WC; Schurig JE
Anticancer Res; 1992; 12(3):959-64. PubMed ID: 1622154
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity and toxicity in animals of BMY-25282, a new mitomycin derivative.
Bradner WT; Rose WC; Schurig JE; Florczyk AP; Huftalen JB; Catino JJ
Cancer Res; 1985 Dec; 45(12 Pt 1):6475-81. PubMed ID: 3933826
[TBL] [Abstract][Full Text] [Related]
7. Effects of mitomycin on human colon carcinoma cells.
Long BH; Willson JK; Brattain DE; Musial S; Brattain MG
J Natl Cancer Inst; 1984 Oct; 73(4):787-92. PubMed ID: 6434780
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT 116 human colon cancer cells.
Pan SS; Yu F; Hipsher C
Mol Pharmacol; 1993 Jun; 43(6):870-7. PubMed ID: 8316219
[TBL] [Abstract][Full Text] [Related]
9. The importance of DT-diaphorase in mitomycin C resistance in human colon cancer cell lines.
Lambert PA; Kang Y; Greaves B; Perry RR
J Surg Res; 1998 Dec; 80(2):177-81. PubMed ID: 9878310
[TBL] [Abstract][Full Text] [Related]
10. DNA interstrand cross-link and free radical formation in a human multidrug-resistant cell line from mitomycin C and its analogues.
Dusre L; Rajagopalan S; Eliot HM; Covey JM; Sinha BK
Cancer Res; 1990 Feb; 50(3):648-52. PubMed ID: 2153443
[TBL] [Abstract][Full Text] [Related]
11. Nonenzymatic reductive activation of 7-N-((2-([2-(gamma-L-glutamylamino)ethyl]dithio)ethyl))mitomycin C by thiol molecules: a novel mitomycin C derivative effective on mitomycin C-resistant tumor cells.
Lee JH; Naito M; Tsuruo T
Cancer Res; 1994 May; 54(9):2398-403. PubMed ID: 8162587
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a human bladder cancer cell line selected for resistance to BMY 25067, a novel analogue of mitomycin C.
Singh SV; Xu BH; Gupta V; Emerson EO; Zaren HA; Jani JP
Cancer Lett; 1995 Aug; 95(1-2):49-56. PubMed ID: 7656243
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of 7-N-[[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]]-mitomycin C.
Morimoto M; Ashizawa T; Ohno H; Azuma M; Kobayashi E; Okabe M; Gomi K; Kono M; Saitoh Y; Kanda Y
Cancer Res; 1991 Jan; 51(1):110-5. PubMed ID: 1988076
[TBL] [Abstract][Full Text] [Related]
14. Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells.
Wallner KE; Banda M; Li GC
Cancer Res; 1987 Mar; 47(5):1308-12. PubMed ID: 3102043
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity and hematotoxicity of a new, substituted dihydrobenzoxazine, FK973, in mice.
Shimomura K; Manda T; Mukumoto S; Masuda K; Nakamura T; Mizota T; Matsumoto S; Nishigaki F; Oku T; Mori J
Cancer Res; 1988 Mar; 48(5):1166-72. PubMed ID: 3342397
[TBL] [Abstract][Full Text] [Related]
16. Overcoming mitomycin C resistance with semisynthetic derivatives.
Brattain MG; Willson JK; Long BH; Chakrabarty S; Yeoman LC; Stringfellow DA
Prog Clin Biol Res; 1986; 223():63-79. PubMed ID: 3101070
[No Abstract] [Full Text] [Related]
17. Detection of mitomycin C-DNA adducts in human breast cancer cells grown in culture, as xenografted tumors in nude mice, and in biopsies of human breast cancer patient tumors as determined by (32)P-postlabeling.
Warren AJ; Mustra DJ; Hamilton JW
Clin Cancer Res; 2001 Apr; 7(4):1033-42. PubMed ID: 11309355
[TBL] [Abstract][Full Text] [Related]
18. [Recent advanced studies on mitomycins, antitumor activity and mode of action].
Taguchi T; Morimoto M
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2396-409. PubMed ID: 3111386
[TBL] [Abstract][Full Text] [Related]
19. [Combination cancer chemotherapy of human gastric and colon carcinomas in nude mice--sequential cancer chemotherapy involving mitomycin C and tegafur].
Kubota T; Ishibiki K; Abe O
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):938-44. PubMed ID: 3083789
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity and toxicity in animals of N-7[2-(4-nitrophenyldithio) ethyl] mitomycin C (BMY-25067).
Bradner WT; Rose WC; Schurig JE; Florczyk AP
Invest New Drugs; 1990; 8 Suppl 1():S1-7. PubMed ID: 2380013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
